PointState Capital’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $347M | Buy |
20,712,398
+5,580,910
| +37% | +$93.5M | 5.29% | 1 |
|
|
2025
Q1 | $233M | Buy |
15,131,488
+1,605,013
| +12% | +$24.7M | 3.37% | 5 |
|
|
2024
Q4 | $298M | Buy |
13,526,475
+3,768,131
| +39% | +$83M | 5.43% | 2 |
|
|
2024
Q3 | $176M | Buy |
9,758,344
+611,621
| +7% | +$11M | 3.19% | 6 |
|
|
2024
Q2 | $149M | Buy |
9,146,723
+4,041,754
| +79% | +$65.7M | 3.23% | 8 |
|
|
2024
Q1 | $72M | Buy |
+5,104,969
| New | +$72M | 1.23% | 15 |
|
|
2018
Q3 | – | Sell |
-6,654,040
| Closed | -$162M | – | 168 |
|
|
2018
Q2 | $162M | Buy |
+6,654,040
| New | +$162M | 1.83% | 17 |
|
|
2016
Q4 | – | Sell |
-9,033,053
| Closed | -$416M | – | 156 |
|
|
2016
Q3 | $416M | Sell |
9,033,053
-5,918,607
| -40% | -$272M | 4.29% | 1 |
|
|
2016
Q2 | $751M | Buy |
14,951,660
+6,679,082
| +81% | +$335M | 15.47% | 1 |
|
|
2016
Q1 | $443M | Sell |
8,272,578
-816,931
| -9% | -$43.7M | 11.93% | 1 |
|
|
2015
Q4 | $597M | Buy |
9,089,509
+4,137,079
| +84% | +$272M | 15.16% | 1 |
|
|
2015
Q3 | $280M | Sell |
4,952,430
-4,753,161
| -49% | -$268M | 7.82% | 3 |
|
|
2015
Q2 | $574M | Sell |
9,705,591
-604,374
| -6% | -$35.7M | 6.71% | 2 |
|
|
2015
Q1 | $642M | Buy |
10,309,965
+2,216,808
| +27% | +$138M | 8.69% | 1 |
|
|
2014
Q4 | $465M | Sell |
8,093,157
-2,297,024
| -22% | -$132M | 7.93% | 1 |
|
|
2014
Q3 | $558M | Sell |
10,390,181
-2,084,924
| -17% | -$112M | 10.13% | 1 |
|
|
2014
Q2 | $654M | Sell |
12,475,105
-261,395
| -2% | -$13.7M | 8.22% | 2 |
|
|
2014
Q1 | $673M | Buy |
12,736,500
+3,291,100
| +35% | +$174M | 10.71% | 2 |
|
|
2013
Q4 | $379M | Buy |
+9,445,400
| New | +$379M | 4.78% | 3 |
|